19th Annual CMHC On Demand

Please note the recordings from the 19th Annual meeting will be accessible on December 6, 2024. 

There is a registration fee for this activity (if you were a live attendee please refer to the below note). Registration can be found here. Once registration is complete, you will receive a confirmation email with an access code and link back to this course.

If you attended the 2024 annual meeting, please reach out to [email protected] and we will provide you with complimentary access code to this activity.

Target Audience

The educational design of this activity addresses the needs of US-based healthcare professionals, including cardiologists, endocrinologists, lipidologists, primary care clinicians (PCPs), registered nurses, advanced practice registered nurses, dieticians, pharmacists, and other allied health professionals involved in the management and treatment of cardiometabolic patients.

Learning Objectives

After completing this activity, the participant should be better able to:

  • Discuss the interrelationships among cardiometabolic risk factors and their impact on the development of cardiometabolic diseases, including diabetes, dyslipidemia, hypertension, obesity, kidney disease, and cardiovascular disease
  • Interpret the latest evidence and guidelines for the prevention, screening, and treatment of the complex patient with cardiometabolic risk or cardiometabolic disease
  • Outline strategies aimed at timely screening and prevention of cardiometabolic disease, including assessment of risk factors and lifestyle modifications
  • Develop individualized treatment regimens for patients with cardiometabolic disease based on the efficacy and safety of current and new pharmacotherapies, patient comorbidities and preferences in order to optimize outcomes
  • Summarize recent evidence for emerging therapies in order to stay current with the most recent updates in the cardiometabolic field
Course summary
Available credit: 
  • 14.00 ACPE Pharmacy
  • 14.00 AMA PRA Category 1 Credit™
  • 14.00 ANCC
  • 14.00 CDE
  • 14.00 Participation
Course opens: 
12/06/2024
Course expires: 
12/06/2025
Rating: 
0

FDA Update and Keynote

FDA Update and Late Breaking Trials
Moderator: Christie M. Ballantyne, MD
Presenters: Deepak L. Bhatt, MD; Robert H. Eckel, MD; Keith C. Ferdinand, MD; Anne L. Peters, MD

KEYNOTE
Prevention and Treatment of Atherosclerosis
Peter Libby, MD

Session I: CardioRenal

Opening Remarks

Keith C. Ferdinand, MD

Current and Emerging Therapies for Resistant Hypertension
Supported by an educational grant from ReCor Medical.
Keith C. Ferdinand, MD

Albuminuria Change as a Marker for CKD Progression
Rajiv Agarwal, MD, MS

Overview of Cardiac Biomarkers for Cardiovascular Risk Stratification
Chiadi Ndumele, MD

Challenging Cardiorenal Cases & Panel Discussion & Audience Questions
Moderator: Keith C. Ferdinand, MD
Panelists: Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC; Chiadi Ndumele, MD

Session II: Obesity

Opening Remarks
Robert H. Eckel, MD

Delving into Behavioral Approaches to Manage Obesity for Optimum Cardiometabolic Health
Sam Dagogo-Jack, MD, DSc, MBA

Ultra-Processed Food Addiction: Signs and Solutions
Erica M. LaFata, PhD

Advances in Obesity Pharmacotherapy
Louis J. Aronne, MD

Sleep Disorders and Cardiometabolic Health
Virend K. Somers, MD, PhD

Challenges in Surgical Approaches to Obesity: Patient Selection, Procedures, Weight Regain
Dimitrios Stefanidis, PhD, MD

Challenging Obesity Management Cases & Panel Discussion & Audience Questions
Moderator: Robert H. Eckel, MD
Panelists: Louis J. Aronne, MD; Sam Dagogo-Jack, MD, DSc, MBA; Erica M. LaFata, PhD; Dimitrios Stefanidis, PhD, MD; Virend K. Somers, MD, PhD

Session III: Diabetes

Opening Remarks
Robert H. Eckel, MD

Precision Medicine in Diabetes
Jose C. Florez, MD, PhD

Expert Perspectives on Initiating and Maintaining Insulin Therapy in Type 2 Diabetes Patients
Jay H. Shubrook, DO, FAAFP, FACOFP

CGM in People Without Diabetes and CVD Risk
Grazia Aleppo, MD, FACE, FACP

How CGM Can Enhance a Patient’s Lifestyle Goals
Grazia Aleppo, MD, FACE, FACP

Challenging Diabetes Management Cases & Panel Discussion & Audience Questions
Moderator: Robert H. Eckel, MD
Panelists: Grazia Aleppo, MD, FACE, FACP; Jose C. Florez, MD, PhD; Jay H. Shubrook, DO, FAAFP, FACOFP

Session IV: Dyslipidemia/Atherosclerosis/Thrombosis

Opening Remarks
Christie M. Ballantyne, MD

LDL Lowering Therapy Beyond Statin
Supported by an educational grant from Esperion Therapeutics.
Pamela B. Morris, MD

How to Improve Cardiovascular Outcomes in Women
Martha Gulati, MD, MS, FACC, FAHA, FASPC, FESC

Primary Prevention of CVD: The Sooner the Better?
Erin D. Michos, MD

Exploring Solutions for Severe Hypertriglyceridemia and FCS: Current Challenges and Progress
Supported by an educational grant from Arrowhead Pharmaceuticals.
Michael D. Shapiro, DO

Understanding Lipoprotein(a): Implications for Cardiovascular Risk and Management
Christie M. Ballantyne, MD

Challenging Lipid Management Cases & Panel Discussion & Audience Questions
Moderator: Christie M. Ballantyne, MD
Panelists: Robert H. Eckel, MD; Martha Gulati, MD, MS, FACC, FAHA, FASPC, FESC; Erin D. Michos, MD; Pamela B. Morris, MD; Michael D. Shapiro, DO

Closing Remarks
Christie M. Ballantyne, MD

ESTIMATED TIME TO COMPLETE ACTIVITY
14 hours

EDUCATIONAL GRANT SUPPORT

This activity is supported in part by an independent educational grant from Novartis Pharmaceuticals Corporation.

JOINT PROVIDERSHIP STATEMENT

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and Cardiometabolic Health Congress (CMHC).  PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CONTINUING EDUCATION
PACE designates this enduring activity for a maximum of 14 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSING CONTINUING EDUCATION
The maximum number of hours awarded for this Continuing Nursing Education activity is 14 contact hours.

Pharmacotherapy contact hours for Advance Practice Registered Nurses will be designated on your certificate.

PHARMACY CONTINUING EDUCATION
PACE designates this continuing education activity for 14 contact hour(s) (1.4 CEUs) of the Accreditation Council for Pharmacy Education.

Universal Activity Number - JA4008073-9999-24-335-H01-P. Type of activity: Application

DIETITIAN CONTINUING EDUCATION
This program offers 14 CPEUs for dietitians.

DISCLOSURES
Information on planner and faculty disclosures can be found PDF icon here

DISCLOSURE OF CONFLICT OF INTEREST
PACE requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.  All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to PACE policies. Others involved in the planning of this activity have no relevant financial relationships.

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

METHOD OF PARTICIPATION & REQUEST FOR CREDIT 
Please note the recordings will be accessible on December 6, 2024. We will notify you if this date changes.

There is a registration fee for this activity (if you were a live attendee please refer to the below note). Registration can be found here. Once registration is complete, you will receive a confirmation email with an access code and link back to this course.

If you attended the 2024 annual meeting, please reach out to [email protected] and we will provide you with complimentary access code to this activity.

During the period December 6, 2024 through December 6, 2025, participants must read the learning objectives and faculty disclosures, study the educational activity and complete the evaluation.  Upon completing, your certificate will be available for print. For questions about receiving certificates, please contact us at [email protected].

For additional information about the accreditation of this activity, please visit https://partnersed.com

For Pharmacists: Please complete the evaluation instructions above. Upon registering and completing the activity evaluation, your transcript information will be sent to the NABP CPE Monitor Service within 4-6 weeks.

Available Credit

  • 14.00 ACPE Pharmacy
  • 14.00 AMA PRA Category 1 Credit™
  • 14.00 ANCC
  • 14.00 CDE
  • 14.00 Participation
Please login or register to take this course.

Please note the recordings will be accessible on December 6, 2024. We will notify you if this date changes.

There is a registration fee for this activity (if you were a live attendee please refer to the below note). Registration can be found here. Once registration is complete, you will receive a confirmation email with an access code and link back to this course.

If you attended the 2024 annual meeting, please reach out to [email protected] and we will provide you with complimentary access code to this activity.

During the period December 6, 2024 through December 6, 2025, participants must read the learning objectives and faculty disclosures, study the educational activity and complete the evaluation.  Upon completing, your certificate will be available for print. For questions about receiving certificates, please contact us at [email protected].

For additional information about the accreditation of this activity, please visit https://partnersed.com

For Pharmacists: Please complete the evaluation instructions above. Upon registering and completing the activity evaluation, your transcript information will be sent to the NABP CPE Monitor Service within 4-6 weeks.

Required Hardware/software

A computer with an internet connection

Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser

Other additional software may be required such as PowerPoint or Adobe Acrobat Reader.